Table 1.
Characteristics of first AMI patients in Denmark in 1995–97, 1998–99 and 2000–02
| 1995–97 | 1998–99 | 2000–02 | |
|---|---|---|---|
| n (% men)* | 15 263 (64.4) | 12 099 (64.8) | 17 857 (62.7) |
| Age groups, n (%) | |||
| 30–44 years | 711 (4.7) | 585 (4.8) | 818 (4.6) |
| 45–54 years* | 2 189 (14.3) | 1 741 (14.4) | 2 339 (13.1) |
| 55–64 years | 3 391 (22.2) | 2 789 (23.1) | 3 873 (21.7) |
| 65–74 years* | 4 424 (29.0) | 3 354 (27.7) | 4 806 (26.9) |
| 75–84 years* | 3 538 (23.2) | 2 795 (23.1) | 4 479 (25.1) |
| ≥85 years* | 1 010 (6.6) | 835 (6.9) | 1 542 (8.6) |
| Concomitant medication (%)† | |||
| Prior statins* | 2.0 | 4.0 | 7.0 |
| Antidiabetic drugs* | 8.9 | 9.5 | 10.7 |
| Loop diuretics | 35.4 | 34.6 | 35.0 |
| Admitting hospital type (%) | |||
| Local community hospital* | 25.1 | 23.1 | 20.9 |
| Main regional hospital* | 60.3 | 60.4 | 61.4 |
| Tertiary cardiac care centre* | 14.6 | 16.6 | 17.8 |
*
Test for trend in a logistic regression between groups: P < 0.05;
†
Statin: 6 months before admission. Antidiabetic drugs and loop diuretics: 3 months before and 1 month after admission.